Johnson & Johnson »

D Fluidigm Corp Del shares owned by Johnson & Johnson

Quarter-by-quarter ownership of D Fluidigm Corp Del (LAB) shares owned by Johnson & Johnson from 13F filings

Historical chart of Johnson & Johnson investment in D Fluidigm Corp Del

Tip: Access up to 7 years of quarterly data

All positions including D Fluidigm Corp Del held by Johnson & Johnson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in D Fluidigm Corp Del by Johnson & Johnson

Quarter filed Position value Share count Share price at filing
2024-03-31 $845k 312k 2.71

More positions owned by Johnson & Johnson

Kenvue (KVUE)
Fusion Pharmaceuticals (FUSN)
CVRX (CVRX)
Protagonist Therapeutics (PTGX)
Shockwave Med (SWAV)
Legend Biotech Corporation Ads (LEGN)
Meiragtx Holdings (MGTX)
Nanobiotix Sponsored Ads (NBTX)
Neumora Therapeutics (NMRA)
Fate Therapeutics (FATE)
Procept Biorobotics Corp (PRCT)
Xencor (XNCR)
Arrowhead Pharmaceuticals (ARWR)
Vor Biopharma (VOR)
Nano-X Imaging Ord Shs (NNOX)

View all positions for Johnson & Johnson

Top funds holding D Fluidigm Corp Del

Casdin Capital
Viking Global Investors
Millennium Management
ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Morgan Stanley
Indaba Capital Management
BlackRock
Balyasny Asset Management
Neuberger Berman Group
Barclays
Goldman Sachs Group
PRIMECAP Management Company

View all funds holding D Fluidigm Corp Del